CollPlant Biotechnologies Ltd. (CLGN) vs Gelteq Limited Ordinary Shares (GELS)
A side-by-side comparison of CollPlant Biotechnologies Ltd. and Gelteq Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLGN
CollPlant Biotechnologies Ltd.
$3.39HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
GELS
Gelteq Limited Ordinary Shares
$0.54HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CLGN vs GELS
growth of $100 · dividends reinvested · last 2yCLGN -91.3% (-70.5%/yr)GELS -81.5% (-57.0%/yr)GELS compounded faster over this window
CLGN GELS
CLGN vs GELS: by the numbers
- •GELS is the larger company ($5M vs $4M market cap).
- •Both run net losses; CLGN's is the smaller (-3934.91% vs -4011.86% net margin).
Metrics side by side
Valuation
| Metric | CLGN | GELS |
|---|---|---|
| P/S ratio | 13.82 | N/A |
| P/B ratio | 1.49 | 0.53 |
Profitability
| Metric | CLGN | GELS |
|---|---|---|
| Gross margin | 26.32% | 100.00% |
| Operating margin | -484.31% | -3317.65% |
| Net margin | -3934.91% | -4011.86% |
| ROE | -424.89% | -42.05% |
| ROIC | -221.32% | -27.41% |
Growth (annualized)
| Metric | CLGN | GELS |
|---|---|---|
| Revenue CAGR (5Y) | -56.28% | N/A |
| Total return CAGR (5Y) | -53.69% | N/A |
Go deeper
Dig into the metrics
CollPlant Biotechnologies ROEGelteq Limited Ordinary Shares ROECollPlant Biotechnologies operating marginGelteq Limited Ordinary Shares operating marginCollPlant Biotechnologies revenue growthGelteq Limited Ordinary Shares revenue growthCollPlant Biotechnologies free cash flowGelteq Limited Ordinary Shares free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.